Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) FCF Margin (2016 - 2019)

Phio Pharmaceuticals' FCF Margin history spans 8 years, with the latest figure at 10357.14% for Q1 2019.

  • For Q1 2019, FCF Margin fell 206584.0% year-over-year to 10357.14%; the TTM value through Dec 2019 reached 41509.52%, down 3605663.0%, while the annual FY2024 figure was 2845.2%, 11664369.0% up from the prior year.
  • FCF Margin reached 10357.14% in Q1 2019 per PHIO's latest filing, down from 3521.05% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 3206.9% in Q2 2018 to a low of 29250.0% in Q1 2016.
  • Average FCF Margin over 5 years is 11973.74%, with a median of 9324.22% recorded in 2018.
  • Peak YoY movement for FCF Margin: skyrocketed 527302bps in 2015, then crashed -2342647bps in 2016.
  • A 5-year view of FCF Margin shows it stood at 5823.53% in 2015, then plummeted by -255bps to 20666.67% in 2016, then grew by 29bps to 14673.33% in 2017, then skyrocketed by 76bps to 3521.05% in 2018, then tumbled by -194bps to 10357.14% in 2019.
  • Per Business Quant, the three most recent readings for PHIO's FCF Margin are 10357.14% (Q1 2019), 3521.05% (Q3 2018), and 3206.9% (Q2 2018).